Testing for myocarditis involves a combination of blood work, heart imaging, and electrical monitoring, because no single test can confirm or rule it out on its own. The diagnosis is built in layers: initial tests raise suspicion, advanced imaging strengthens the case, and in some situations a tissue sample from the heart provides definitive proof. Here’s what each step involves and what doctors are looking for.
Blood Tests: The First Step
When myocarditis is suspected, blood work is typically the starting point. Doctors look for troponin, a protein released into the bloodstream when heart muscle cells are damaged. Elevated troponin signals that something is injuring the heart, but it doesn’t pinpoint the cause. The same marker rises during a heart attack, which is one reason myocarditis can be tricky to distinguish from other cardiac emergencies. Troponin alone isn’t sensitive or specific enough to confirm myocarditis, so it serves more as a red flag than a definitive answer.
Other blood markers may include tests that measure inflammation in the body and a hormone called BNP (or its variant NT-proBNP), which rises when the heart is under strain. These results help paint a picture of how much stress and inflammation the heart is dealing with, but again, they’re supporting evidence rather than proof.
Viral blood tests are sometimes ordered, but their usefulness is limited. Elevated antibody levels against a particular virus don’t confirm that the virus is actually attacking the heart. Current guidelines recommend targeted testing only when a specific treatable infection is suspected, such as HIV, hepatitis C, or Lyme disease, since those results would directly change treatment.
Electrocardiogram (ECG)
An ECG records the electrical activity of your heart through electrodes placed on your chest. In myocarditis, the most common findings are a faster-than-normal heart rate and nonspecific changes in the electrical patterns called ST-segment and T-wave abnormalities. These changes reflect irritation or damage to the heart muscle.
Other possible ECG findings include widening of the electrical signal (prolonged QRS), a longer-than-normal interval between beats (QT prolongation), inverted T-waves across multiple leads, and various rhythm disturbances. Arrhythmias occur in up to 45% of cases in children. When inflammation extends to the sac surrounding the heart, the ECG may also show patterns typical of pericarditis, a related condition.
The challenge with ECG is that these findings overlap with many other heart conditions, including heart attacks. An ECG can look alarming enough to prompt emergency evaluation, but it can’t distinguish myocarditis from a blocked coronary artery on its own.
Echocardiogram: Assessing Heart Function
An echocardiogram is an ultrasound of the heart. It shows how well the heart is pumping, whether the walls are thickened or thinned, and whether specific regions of the heart are contracting abnormally. In myocarditis, doctors may see areas where the heart wall moves weakly (hypokinesis), fails to contract at all (akinesis), or bulges outward when it should be squeezing inward (dyskinesis).
These wall motion abnormalities aren’t unique to myocarditis. They also appear after heart attacks, in certain inherited heart conditions, and in stress-related heart syndromes. What the echocardiogram does well is quantify the damage: it measures the ejection fraction (the percentage of blood pumped out with each beat), which helps determine how severely the heart is affected and guides decisions about treatment intensity.
Coronary Angiography: Ruling Out a Heart Attack
Because myocarditis can closely mimic a heart attack, with chest pain, elevated troponin, and ECG changes, many patients end up in the catheterization lab. A coronary angiogram threads a thin tube into the arteries of the heart and injects dye to check for blockages. Roughly 3% of patients who present with what looks like a heart attack turn out to have completely normal coronary arteries.
In one study of 45 patients admitted with suspected heart attacks who had normal coronary angiograms, 38% were ultimately diagnosed with diffuse myocarditis, and another 40% showed findings suggestive of focal or patchy inflammation. So coronary angiography doesn’t diagnose myocarditis directly. Instead, it eliminates the most dangerous alternative explanation, clearing the path for further testing.
Cardiac MRI: The Key Imaging Test
Cardiac MRI is the most important noninvasive tool for diagnosing myocarditis. It can visualize inflammation and scarring in the heart muscle with a level of detail that echocardiography and ECG cannot match. You’ll lie in an MRI scanner for 45 to 90 minutes while the machine captures detailed images of your heart, often with an injected contrast agent called gadolinium.
Doctors interpret the images using a standardized framework known as the updated Lake Louise Criteria. A diagnosis of myocarditis on MRI requires two types of findings. First, evidence of swelling (edema) in the heart muscle, detected through a technique called T2-based imaging. This shows active inflammation. Second, evidence of tissue injury, detected through T1-based imaging or the characteristic pattern of gadolinium “lighting up” in areas of damaged heart muscle. The gadolinium enhancement pattern in myocarditis typically appears in the middle or outer layers of the heart wall, which helps distinguish it from a heart attack, where damage is concentrated in the inner layer fed by a blocked artery.
In adults, a large meta-analysis found that the individual imaging markers had sensitivities ranging from 68% to 89% and specificities from 76% to 96%, depending on the technique used. T1 mapping performed best overall for sensitivity (89%) and specificity (90%). In a smaller pediatric study, sensitivities for T1, T2, and a measure of tissue water content called extracellular volume ranged from 86% to 91%, with specificities between 74% and 89%. These numbers are strong but not perfect, which means a normal cardiac MRI makes myocarditis less likely but doesn’t completely exclude it.
Endomyocardial Biopsy: Definitive but Rarely Done
A heart biopsy, or endomyocardial biopsy, is the only way to definitively prove myocarditis. A catheter is guided into the right side of the heart, and tiny samples of tissue are snipped from the inner wall. These samples are examined under a microscope using a set of criteria called the Dallas Criteria, which look for inflammatory cells invading the heart muscle alongside evidence of muscle cell damage. If inflammatory cells are present but there’s no visible damage to muscle cells, the result is classified as “borderline myocarditis.”
Despite being the gold standard in theory, biopsy has significant practical limitations. The inflammation in myocarditis is often patchy rather than spread evenly across the heart, so a small sample may miss affected areas entirely. The sampling error rate exceeds 25%, and different pathologists can interpret the same sample differently. Among patients with new-onset heart dysfunction who undergo biopsy, only about 10% meet the strict Dallas Criteria for myocarditis.
Because of these limitations and the small but real risk of complications from an invasive heart procedure, biopsy is reserved for specific situations. It’s most commonly performed when the diagnosis would change management, such as when doctors suspect a cause like giant cell myocarditis or cardiac sarcoidosis that requires aggressive immune-suppressing treatment, or when a patient is deteriorating rapidly despite standard care.
Testing in Children and Adolescents
Diagnosing myocarditis in children presents additional challenges. Younger children can’t always describe chest pain or other symptoms clearly, and the initial presentation varies widely. About two-thirds of children have a history of a recent viral illness before symptoms appear. Fever is present in over 50% of pediatric cases, and roughly 10% present with fainting. Myocarditis has been identified in 6% of cases of sudden cardiac death in young athletes in the United States.
The same tests used in adults apply to children, but interpreting them requires pediatric expertise. Cardiac MRI is highly valuable in this age group, though younger children may need sedation to stay still in the scanner. As with adults, a positive biopsy confirms the diagnosis, but a negative result doesn’t rule it out. There are no clinical criteria based on symptoms alone that can definitively confirm myocarditis in children, so doctors rely on combining multiple test results with the overall clinical picture.
How the Pieces Fit Together
In practice, testing for myocarditis follows a predictable sequence. A patient arrives with chest pain, shortness of breath, or a new arrhythmia. Blood work shows elevated troponin and inflammatory markers. An ECG shows electrical abnormalities. An echocardiogram reveals reduced heart function or abnormal wall motion. If coronary angiography shows clean arteries, the suspicion shifts strongly toward myocarditis, and cardiac MRI becomes the pivotal test.
For most patients, the combination of clinical presentation, blood work, and cardiac MRI findings is enough to make a confident working diagnosis without a biopsy. The process can feel drawn out, especially when you’re anxious about your heart, but each layer of testing narrows the possibilities and helps your care team determine both the diagnosis and how aggressively it needs to be treated.